Literature DB >> 10995244

Low-temperature optical absorption spectra suggest a redox role for tetrahydrobiopterin in both steps of nitric oxide synthase catalysis.

A C Gorren1, N Bec, A Schrammel, E R Werner, R Lange, B Mayer.   

Abstract

To investigate the role of tetrahydrobiopterin (BH4) in the catalytic mechanism of nitric oxide synthase (NOS), we analyzed the spectral changes following addition of oxygen to the reduced oxygenase domain of endothelial nitric oxide synthase (NOS) in the presence of different pteridines at -30 degrees C. In the presence of N(G)-hydroxy-L-arginine (NOHLA) and BH4 or 5-methyl-BH4, both of which support NO synthesis, the first observable species were mixtures of high-spin ferric NOS (395 nm), ferric NO-heme (439 nm), and the oxyferrous complex (417 nm). With Arg, no clear intermediates could be observed under the same conditions. In the presence of the BH4-competitive inhibitor 7,8-dihydrobiopterin (BH2), intermediates with maxima at 417 and 425 nm were formed in the presence of Arg and NOHLA, respectively. In the presence of 4-amino-BH4, the maxima of the intermediates with Arg and NOHLA were at 431 and 423 nm, respectively. We ascribe all four spectra to oxyferrous heme complexes. The intermediates observed in this study slowly decayed to the high-spin ferric state at -30 degrees C, except for those formed in the presence of 4-amino-BH4, which required warming to room temperature for regeneration of high-spin ferric NOS; with Arg, regeneration remained incomplete. From these observations, we draw several conclusions. (1) BH4 is required for reductive oxygen activation, probably as a transient one-electron donor, not only in the reaction with Arg but also with NOHLA; (2) in the absence of redox-active pterins, reductive oxygen activation does not occur, which results in accumulation of the oxyferrous complex; (3) the spectral properties of the oxyferrous complex are affected by the presence and identity of the substrate; (4) the slow and incomplete formation of high-spin ferric heme with 4-amino-BH4 suggests a structural cause for inhibition of NOS activity by this pteridine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995244     DOI: 10.1021/bi0007775

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Structural studies of constitutive nitric oxide synthases with diatomic ligands bound.

Authors:  Huiying Li; Jotaro Igarashi; Joumana Jamal; Weiping Yang; Thomas L Poulos
Journal:  J Biol Inorg Chem       Date:  2006-06-28       Impact factor: 3.358

2.  Electron paramagnetic resonance characterization of tetrahydrobiopterin radical formation in bacterial nitric oxide synthase compared to mammalian nitric oxide synthase.

Authors:  Albane Brunel; Jérôme Santolini; Pierre Dorlet
Journal:  Biophys J       Date:  2012-07-03       Impact factor: 4.033

3.  Tetrahydrobiopterin redox cycling in nitric oxide synthase: evidence supports a through-heme electron delivery.

Authors:  Somasundaram Ramasamy; Mohammad Mahfuzul Haque; Mahinda Gangoda; Dennis J Stuehr
Journal:  FEBS J       Date:  2016-11-18       Impact factor: 5.542

4.  Reduction of ferric haemoproteins by tetrahydropterins: a kinetic study.

Authors:  Chantal Capeillere-Blandin; Delphine Mathieu; Daniel Mansuy
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells.

Authors:  Toru Sugiyama; Bruce D Levy; Thomas Michel
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

6.  Formation of transient oxygen complexes of cytochrome p450 BM3 and nitric oxide synthase under high pressure.

Authors:  Stéphane Marchal; Hazel Mary Girvan; Antonius C F Gorren; Bernd Mayer; Andrew William Munro; Claude Balny; Reinhard Lange
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

7.  Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure.

Authors:  An L Moens; Elizabeth A Ketner; Eiki Takimoto; Tim S Schmidt; Charles A O'Neill; Michael S Wolin; Nicholas J Alp; Keith M Channon; David A Kass
Journal:  J Mol Cell Cardiol       Date:  2011-05-30       Impact factor: 5.000

Review 8.  Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease.

Authors:  Jermaine Goveia; Peter Stapor; Peter Carmeliet
Journal:  EMBO Mol Med       Date:  2014-09       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.